I thought readers of this blog might be interested in an interview series I am running on race and medicine on my other blog, Envisioning 2.0. To date, I have run three interviews in this series. It is titled, "Conversations About Race-Based Medicine."
In upcoming weeks, I will be publishing a conversation I had with NitroMed on this topic. NitroMed makes BiDil, the first medication ever approved for the treatment of a specific racial group: self-identified African Americans with heart failure.
Click here to read a press release on this series. Click here to read the interviews. I will publish the final four conversations on Envisioning 2.0 in April and May.
In upcoming weeks, I will be publishing a conversation I had with NitroMed on this topic. NitroMed makes BiDil, the first medication ever approved for the treatment of a specific racial group: self-identified African Americans with heart failure.
Click here to read a press release on this series. Click here to read the interviews. I will publish the final four conversations on Envisioning 2.0 in April and May.
Comment Preview